In 2020, the list of newly recognized provincial enterprise research institutes was officially announced
Recently, the Department of science and technology of Zhejiang Province, the development and Reform Commission of Zhejiang Province and the Department of economy and information technology of Zhejiang Province jointly issued a document. According to the spirit of the administrative measures of Zhejiang Enterprise Research Institute and the Circular of Zhejiang Department of science and technology on organizing the application for 2020 provincial enterprise research institutes, 301 enterprises were announced after review and publicity on the basis of recommendation by districts and cities The list of "newly recognized provincial enterprise research institutes in 2020" is prominently listed by Zhejiang Bioer Molecular Biotechnology Research Institute under Hangzhou Bioer Co., Ltd. located in Hangzhou high tech Industrial Development Zone.
Bioer was officially selected into the "list of newly recognized provincial enterprise research institutes in 2020"
Zhejiang Bioer Molecular Biotechnology Research Institute complies with the trend, focuses on molecular diagnosis technology, carries out innovative exploration from basic research to clinical transformation in an all-round way, is committed to technological innovation and industrialization in the field of molecular diagnosis, promotes the sustainable development of the industry and shortens the gap with the world's advanced level.
What is the provincial enterprise research institute?
"Provincial enterprise research institute" refers to a comprehensive research and development institution established by large provincial enterprises, with the ability to organize and carry out scientific and technological innovation activities, and approved by relevant provincial departments.
In addition to going through a scientific, standardized and rigorous review process, the selected enterprises also have a clear indicator threshold: the sales revenue of the previous year reached more than 100 million yuan, of which the proportion of development expenses in sales revenue was not less than 3%, or the research and development expenses reached 10 million yuan, more than 50 full-time research and development personnel, and the relatively concentrated R & D site was more than 1000 square meters, The original value of scientific research equipment is more than 10 million yuan.
Bioer Health Industrial Park
Hangzhou Bioer Co., Ltd. is a national high-tech enterprise. The company is located by the beautiful Qiantang River, covering an area of 26000 square meters and has more than 400 employees. Bioer has focused on the PCR field for more than 26 years and obtained the registration certificate of China fluorescence quantitative PCR detection system in 2002, realizing a milestone breakthrough in the PCR field in China. Bioer has now developed into a world-famous PCR industry base, providing customers with a full range of solutions in life science research and application fields such as instruments, reagents and consumables.
Bioer has established an international R & D team, established close cooperative relations with many research institutions in Germany, Japan and other countries, established a provincial high-tech R & D center, and has more than 100 core R & D personnel. Bioer provides customers with a complete set of solutions for PCR laboratory construction, nucleic acid sample collection, preservation and transportation, nucleic acid extraction, purification and detection. Its application directions include scientific research, medical diagnosis, food safety, pet detection, epidemic disease detection, aquatic disease detection and other fields.
In line with the business philosophy of "diligence and determination, development and excellence", Bioer has established a perfect quality management system and passed ISO9001 and ISO13485 certification. Its products have more than 40 registration certificates of various medical devices and 73 patents. The global sales network now covers more than 121 countries and regions in the world, such as China, the United States, Germany, Canada, Finland, Japan, South Korea, Southeast Asia, South America and the Middle East.
Novel coronavirus pneumonia has been actively involved in the Bioer epidemic. It has participated in the anti epidemic work of the African SARS fever and the new crown pneumonia in 2003, SARS, H1N1 and 2019 in 2009. It has donated free emergency supplies, testing reagents and instruments for many times, and has opened the demand channel for donation of materials, and has served the front line of epidemic prevention and treatment with the high quality service efficiency.
Bioer actively fights the epidemic
This time, it was selected as "2020 Zhejiang provincial enterprise research institute", which provides strong confidence and source power for the company's future development. In the future, Bioer will continue to pay attention to demand, all staff will be on standby, respond quickly, better serve customers and society, take establishing a national brand as its mission, and show more Chinese power on the global stage!
--> Return to list